Biotech Values

[rkrw]

But if I'm understanding right, the randomization only takes place when vaccination occurs. The goal is can they extend remission. So going back the 6 months isn't an ITT since no one had been treated.

My guess is yesterdays release was mainly intended to get a preliminary data out and try to pursue a deal rather than wait until final data a few months from now. No deal would be a bad sign. Takeda and pfe have been really active in cancer vaccine deals.

I'm not advocating, maybe the company is a bunch of nut jobs and a 10 year trial is bound to be messy. Panel meeting should be interesting when everything is out there.